Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (6): 10-14.doi: 10.6040/j.issn.1671-7554.0.2021.0324
Previous Articles Next Articles
LUO Xianghang, ZHOU Ruoyu
CLC Number:
| [1] Qaseem A, Forciea MA, McLean RM, et al. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians [J]. Ann Intern Med, 2017, 166(11): 818-839. [2] Feng X, McDonald JM. Disorders of bone remodeling [J]. Annu Rev Pathol, 2011, 6: 121-145. doi:10.1146/annure-pathol-011110-130203. [3] Kruse HP, Kuhlencordt F. Pathogenesis and natural course of primary osteoporosis [J]. Lancet, 1980, 1(8163): 280-282. [4] Walker-Bone K. Recognizing and treating secondary osteoporosis [J]. Nat Rev Rheumatol, 2012, 8(8): 480-492. [5] Hadjidakis DJ, Androulakis. Bone remodeling [J]. Ann N Y Acad Sci, 2006, 1092: 385-396. doi: 10.1196/annals.1365.035. [6] Karsenty G. The central regulation of bone remodeling [J]. Trends Endocrinol Metab, 2000, 11(10): 437-439. [7] Zhang L, Su P, Xu C, et al. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression [J]. J Pineal Res, 2010, 49(4): 364-372. [8] Li CJ, Xiao Y, Yang M, et al. Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging [J]. J Clin Invest, 2018, 128(12): 5251-5266. [9] Ortinau LC, Wang H, Lei K, et al. Identification of functionally distinct Mx1+αSMA+ periosteal skeletal stem cells [J]. Cell Stem Cell, 2019, 25(6): 784-796.e785. [10] Debnath S, Yallowitz AR, McCormick J, et al. Discovery of a periosteal stem cell mediating intramembranous bone formation [J]. Nature, 2018, 562(7725): 133-139. [11] Han Y, You X, Xing W, et al. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts [J]. Bone Res, 2018, 6: 16. doi: 10.1038/s41413-018-0019-6. eCollection 2018. [12] Al Rifai O, Chow J, Lacombe J, et al. Proprotein convertase furin regulates osteocalcin and bone endocrine function [J]. J Clin Invest, 2017, 127(11): 4104-4117. [13] Wu M, Chen G, Li YP. TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease [J]. Bone Res, 2016, 4: 16009. doi:10.1038/boneres.2016.9. [14] McGregor NE, Murat M, Elango J, et al. IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis [J]. J Biol Chem, 2019, 294(19): 7850-7863. [15] 张猛, 牛泽锋, 王翠杰, 等. 破骨细胞活性及其调节因子的研究进展[J]. 脊柱外科杂志, 2018, 16(3): 179-182. ZHANG Meng, NIU Zefeng, WANG Cuijie, et al. Research progress of osteoclast activity and its regulating factors [J]. Journal of Spinal Surgery, 2018, 16(3): 179-182. [16] Maré A, DHaese PC, Verhulst A. The role of sclerostin in bone and ectopic calcification [J]. Int J Mol Sci, 2020, 21(9): 3199. doi: 10.3390/ijms21093199. [17] Bullock WA, Hoggatt AM, Horan DJ, et al. Lrp4 mediates bone homeostasis and mechanotransduction through interaction with sclerostin in vivo [J]. iScience, 2019, 20: 205-215. doi: 10.1016/j.isci.2019.09.023. [18] Liu W, Wang Z, Yang J, et al. Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice [J]. Open Biol, 2019, 9(5): 180262. doi: 10.1098/rsob.180262. [19] Fijalkowski I, Geets E, Steenackers E, et al. A novel domain-specific mutation in a sclerosteosis patient suggests a role of LRP4 as an anchor for sclerostin in human bone [J]. J Bone Miner Res, 2016, 31(4): 874-881. [20] Delgado-Calle J, Sato AY, Bellido T, Role and mechanism of action of sclerostin in bone [J]. Bone, 2017, 96: 29-37. doi: 10.1016/j.bone.2016.10.007. [21] Morgan EF, Unnikrisnan GU, Hussein AI. Bone mechanical properties in healthy and diseased states [J]. Annu Rev Biomed Eng, 2018, 20: 119-143. doi: 10.1146/annurev-bioeng-062117-121139. [22] Lee WC, Guntur AR, Long F, et al. Energy metabolism of the osteoblast: implications for osteoporosis [J]. Endocr Rev, 2017, 38(3): 255-266. [23] Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone [J]. Nature, 2014, 507(7492): 323-328. [24] Yang M, Li CJ, Xiao Y, et al. Ophiopogonin D promotes bone regeneration by stimulating CD31(hi)EMCN(hi)vessel formation [J]. Cell Prolif, 2020, 53(3): e12784. doi: 10.1111/cpr.12784. [25] Yang M, Li CJ, Sun X, et al. MiR-497-195 cluster regulates angiogenesis during coupling with osteogenesis by maintaining endothelial Notch and HIF-1α activity [J]. Nat Commun, 2017, 8: 16003. doi: 10.1038/ncomms16003. [26] Ralston SH, Uitterlinden AG. Genetics of osteoporosis [J]. Endocr Rev, 2010, 31(5): 629-662. [27] Zhang L, Yin X, Wang J, et al. Associations between VDR gene polymorphisms and osteoporosis risk and bone mineral density in postmenopausal women: a systematic review and Meta-analysis [J]. Sci Rep, 2018, 8(1): 981. [28] 赵航, 马慧娟, 王超. 骨质疏松症相关基因研究进展[J]. 实用老年医学, 2019, 33(6): 9-13. [29] Zhu X, Zheng H, Factors influencing peak bone mass gain [J]. Front Med, 2021, 15(1): 53-69. [30] Windahl SH, Börjesson AE, Farman HH, et al. Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice [J]. Proc Natl Acad Sci U S A, 2013, 110(6): 2294-2299. [31] Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton [J]. Trends Endocrinol Metab, 2012, 23(11): 576-581. [32] Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts [J]. Cell, 2007, 130(5): 811-823. [33] Almeida M, Laurent MR, Dubois V, et al. Estrogens and androgens in skeletal physiology and pathophysiology [J]. Physiol Rev, 2017, 97(1): 135-187. [34] Li CJ, Cheng P, Liang MK, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation [J]. J Clin Invest, 2015, 125(4): 1509-1522. [35] 王洪复, 于明香. 老年人成骨细胞骨形成功能的衰退与治疗[J]. 国外医学(内分泌学分册), 2003, 23(2): 79-80,97. [36] Hemmatian H, Bakker AD, Klein-Nulend J, et al. Aging, osteocytes, and mechanotransduction [J]. Curr Osteoporos Rep, 2017, 15(5): 401-411. [37] Cai D, Khor S. “Hypothalamic Microinflammation” Paradigm in Aging and Metabolic Diseases [J]. Cell Metab, 2019, 30(1): 19-35. [38] Zhang G, Li J, Purkayastha S, et al. Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH [J]. Nature, 2013, 497(7448): 211-216. [39] Xiao YZ, Yang M, Xiao Y, et al. Reducing hypothalamic stem cell senescence protects against aging-associated physiological decline [J]. Cell Metab, 2020, 31(3): 534-548.e535. [40] Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal andextraskeletal actions of Vitamin D: current evidence and outstanding questions [J]. Endocr Rev, 2019, 40(4): 1109-1151. [41] Polzonetti V, Pucciarelli S, Vincenzetti S, et al. Dietary intake of Vitamin D from dairy products reduces the risk of osteoporosis [J]. Nutrients, 2020, 12(6): 1743. doi: 10.3390/nu12061743. [42] Hardcastle SA, Yahya F, Bhalla AK. Pregnancy-associated osteoporosis: a UK case series and literature review [J]. Osteoporos Int, 2019, 30(5): 939-948. [43] Papageorgiou M, Sathyapalan T, Schutte R. Muscle mass measures and incident osteoporosis in a large cohort of postmenopausal women [J]. J Cachexia Sarcopenia Muscle, 2019, 10(1): 131-139. [44] Li G, Zhang L, Wang D, et al. Muscle-bone crosstalk and potential therapies for sarco-osteoporosis [J]. J Cell Biochem, 2019, 120(9): 14262-14273. [45] McDonald MM, Khoo WH, Ng PY, et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption [J]. Cell, 2021, 184(5): 1330-1347. [46] Fabre S, Funck-Brentano T, Cohen-Solal M. Anti-sclerostin antibodies in osteoporosis and other bone diseases [J]. J Clin Med, 2020, 9(11):3439. doi: 10.3390/jcm9113439. [47] Asadipooya K, Weinstock A. Cardiovascular outcomes of romosozumab and protective role of alendronate [J]. Arterioscler Thromb Vasc Biol, 2019, 39(7): 1343-1350. [48] Ardura JA, Portal-Núñez S, Alonso V, et al. Handling parathormone receptor type 1 in skeletal diseases: realities and expectations of abaloparatide [J]. Trends Endocrinol Metab, 2019, 30(10): 756-766. |
| [1] | LI Jingxiu, LI Zhonghui, LI Wentian, WANG Yunan, SONG Zehui, ZHUANG Dayong, HE Qingqing, ZHOU Peng. Preliminary application of photoelectric detection devices in thyroid cancer surgery [J]. Journal of Shandong University (Health Sciences), 2026, 64(4): 31-37. |
| [2] | Intelligent Orthopedics Subgroup of Chinese Association of Orthopedic, Subgroup for Prevention and Control of Spinal and Spinal Cord Injury Diseases of Professional Committee for Prevention and Control of Spinal Diseases of Chinese Preventive Medicine Association. Expert consensus on measurement sites and annotation of artificial intelligence-based spinal degenerative imaging(2025) [J]. Journal of Shandong University (Health Sciences), 2026, 64(2): 1-10. |
| [3] | LI Xinyuan, ZHANG Xinzhi, DI Derun, YUAN Suomao, LIU Xinyu, WANG Lianlei. Comparative analysis of Cobb angle in weight-bearing 3D automatic imaging and X-ray plain film [J]. Journal of Shandong University (Health Sciences), 2026, 64(2): 89-95. |
| [4] | SONG Yiming, WANG Jiafeng, HAN Xiaojuan, DU Yifeng. Brain maintenance and cognitive function: measurement, influencing factors and mechanism [J]. Journal of Shandong University (Health Sciences), 2026, 64(1): 1-7. |
| [5] | WANG Yibo, WANG Yingchao, XU Linlin, HUANG Shuhong, DANG Ningning. Mechanism of skin aging induced by cigarette smoke extract via the Klotho-CHRNA5 axis [J]. Journal of Shandong University (Health Sciences), 2026, 64(1): 88-98. |
| [6] | JIN Chenxi, SHEN Wei, LI Na, SUN Jianfeng, YANG Chi, GUO Jing. Quantitative analysis of disc-condyle movement following arthroscopic disc repositioning operation for ADDWoR [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 54-61. |
| [7] | YU Yunan, WANG Ping, DAI Junyi, LIU Junfeng, ZAN Junfeng. In vivo anti-aging effect of poria cocos three active ingredients on caenorhabditis elegans [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 1-10. |
| [8] | WANG Lei, CHANG Xiao, WANG Zimeng, LI Jiaojiao, CUI Shujun, YANG Fei, ZHU Yuexiang. Predictive value of intratumoral and peritumoral DCE-MRI imaging histology for progression-free survival in patients with cervical cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 45-54. |
| [9] | ZHANG Yixiang, LIANG Yuanhao, YANG Wenlong, LI Guoqiang, WU Wenqing, LIU Lei. Construction of a transforaminal endoscopic surgical path based on bone landmarks in intraoperative C-arm X-ray radiographs [J]. Journal of Shandong University (Health Sciences), 2025, 63(3): 14-21. |
| [10] | LIN Jinxiu, LI Ye, YIN Dechao, WANG Kunpeng, TAN Baoli. Classification and treatment of irreducible intertrochanteric femoral fractures based on CT 3-D imaging [J]. Journal of Shandong University (Health Sciences), 2025, 63(12): 61-73. |
| [11] | GONG Jie, YU Miao, LI Xiuyong, CHEN Ying, XU Qianru, LI Meijuan, LI Yitong, LIU Xiumei. Construction of polysaccharide probe based on upconversion nanoparticles and its application in tumor bioimaging [J]. Journal of Shandong University (Health Sciences), 2025, 63(11): 18-26. |
| [12] | ZHANG Xinru, LI Yang, SUN Meng, NIE Wei, MA Zhe. Application and evaluation of Vision-LSTM model in diagnostic ultrasound imaging of Thyroid Imaging Reporting and Data System Category 4b thyroid nodules [J]. Journal of Shandong University (Health Sciences), 2025, 63(11): 68-74. |
| [13] | LIANG Yanchun, YAN Ying, MAI Huaxi, YAO Shuzhong. Therapeutic effect of dienogest in endometriosis-associated pain: from fundamental research to clinical practice [J]. Journal of Shandong University (Health Sciences), 2025, 63(10): 27-33. |
| [14] | LIU Jingjing, PANG Jing, ZHAO Xiaodan, LIN Xin, FU Min, CHEN Jingjing. Machine learning model based on mammography and DCE-MRI to predict pathological complete response after neoadjuvant therapy in breast cancer: a dual center research [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 60-72. |
| [15] | LIU Xiaowen, CAO Yongquan, HOU Mingyuan, YU Dexin. Value of multiple quantitative parameters of EOB-MRI in the risk assessment of progression of HHN in hepatobiliary phase [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 31-39. |
|
||
